This inventor holds 1 USPTO granted patent and 4 EPO patents. Top assignee: Genetic Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Marcelo Nicolas Muscara': Innovator in Pharmaceutical Compositions
Introduction
Marcelo Nicolas Muscara' is a notable inventor based in Campinas, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for treating respiratory conditions. His work exemplifies the intersection of science and practical application in medicine.
Latest Patents
Marcelo holds a patent for "Montelukast salts and pharmaceutical compositions containing the same." This invention pertains to salts of Montelukast combined with β2 adrenergic agonists. The pharmaceutical compositions developed from this invention are aimed at treating respiratory inflammatory pathologies, obstructive pathologies, and allergen-induced airway dysfunctions. Additionally, the patent outlines the process for preparing these salts, showcasing his expertise in pharmaceutical formulation.
Career Highlights
Marcelo is currently associated with Genetic S.p.a., where he continues to innovate in the pharmaceutical sector. His work has not only contributed to the advancement of medical treatments but has also positioned him as a key figure in his field. With a patent portfolio that includes 1 patent, he demonstrates a commitment to improving healthcare through scientific research.
Collaborations
Marcelo has collaborated with esteemed colleagues such as Giuseppe Cirino and Giuseppe Caliendo. These partnerships highlight the collaborative nature of innovation in the pharmaceutical industry, where teamwork often leads to groundbreaking discoveries.
Conclusion
In summary, Marcelo Nicolas Muscara' is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact the treatment of respiratory diseases significantly. His contributions reflect a dedication to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile